State Street SPDR S&P Biotech ETF XBI
154.70 USD -2.20 (-1.40%)
Nov 10, 2026, 2:07 PM EST
153.22 Day range 157.85
109.53 52-week range 169.89
- YTD
- +26.88%
- 1 year
- +40.52%
- Market cap
- 8.20B
- YTD return
- +26.88%
- 1-year return
- +40.52%
- Volume
- 4.61M
- Avg volume
- 9.11M
- Open
- 155.22
- Previous close
- 156.90
- Day's range
- 153.22 – 157.85
- 52-week range
- 109.53 – 169.89
5D -2.74 (-1.74%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 155.22
- 200-day average
- 142.31
Next earnings
Consensus EPS estimate 0.00.
About State Street SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
News
Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain? 
Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today 
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach 
Economy Grows 63% in Six Years, 30-Year Treasury Lost Almost As Much 
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets 
Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back 
What's Going On With Novavax Stock? 
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs 
Novavax Stock Climbs Monday: What's Going On? 
QUICK SPARK: $3.8B SPY Exodus Meets $3.7B QQQ Inflow in One Day
Your note
Sign in to keep a note on XBI — it syncs with the Stock Master app.